Industry · NAICS 325412
Pharmaceutical Preparation Manufacturing
Open notices · Coming up for re-bid · Who wins this work · Typical award sizes
Money by year
Obligations (money committed) in prime awards, from USAspending.gov.
Agencies buying it, FY2025
- Department of Veterans Affairs $11.66B
- Department of Health and Human Services $6.66B
- Department of Justice $217.17M
- Department of Defense $88.97M
- Peace Corps $1.54M
- Department of State $873.7K
- Department of the Interior $805.1K
- Department of Agriculture $564.6K
Offices buying the most, FY2025
- Vha Chief Logistics Office (36C240) $11.45B
- CDC Office of Acquisition Services $5.61B
- Aspr/Orm-Sns $582.87M
- Barda - Aspr / Daappo / Barda Dcma $150.26M
- National Institutes of Health - CC $103.73M
- Navajo Area Indian Health SVC $95.64M
- Phoenix Area Indian Health SVC $64.59M
- Dla Troop Support $47.62M
Companies winning it, FY2025
- Mckesson Corp $11.92B
- Merck & Co., Inc. $2.88B
- Sanofi $1.02B
- Glaxosmithkline, LLC $958.75M
- Pfizer Inc $700.60M
- Stroz Friedberg, LLC $227.68M
- Bavarian Nordic A/S $143.57M
- Chartwell RX LLC $114.76M
- Emergent Biosolutions Inc. $113.30M
- Tennessee Valley Authority $102.61M
Where the work is, FY2025
- Texas $11.81B
- (not reported) $5.55B
- New Jersey $376.01M
- (outside the US) $293.74M
- New York $122.66M
- Illinois $115.71M
- Pennsylvania $112.75M
- Oklahoma $83.28M
Contracts ending in the next 12 months
132 contracts, $13.10B with options. The largest:
| Contract | Incumbent | Ends | Value with options |
|---|---|---|---|
| 70CDCR26FR0000037 | Mckesson Corporation | 2026-10-10 | $3.16M |
| 75H71126F80043 THIS ANNUAL PURCHASE ENSURES THAT NSSC MAINTAINS SUFFICIENT QUANTITIES OF THE INFLUENZA VACCINE FOR AGES SIX MONTHS AND OLDER PER CDC RECOMMENDATIONS. THE VACCINE PREVENTS ILLNESSES, MEDICAL VISITS, HOSPITALIZATIONS, AND DEATH. THE REQUIREMENTS ARE S | Seqirus USA Inc | 2026-10-15 | $2.68M |
| 36C26226N0346 LENALIDOMIDE VA SAN DIEGO DO | Exelan Pharmaceuticals Inc | 2026-10-15 | $2.25M |
| 36C24126F0008 CARDIOGEN RADIOPHARMACEUTICAL RUBIDIUM GENERATORS | Bracco Diagnostics Inc. | 2026-10-19 | $2.80M |
| 36C25726N0098 DALLAS VA PHARMACY COMPOUNDING FOR ONCOLOGY DRUGS | Optum Infusion Services 308, LLC | 2026-10-26 | $1.20M |
| 36C26226N0112 PLUVICTO AND LUTATHERA | Novartis Pharmaceuticals Corporation | 2026-10-31 | $4.30M |
| 36C24724F0045 PYLARIFY QTY 80 | Progenics Pharmaceuticals Inc | 2026-10-31 | $3.21M |
| 36C25026N0149 FIVE YEAR FOR PET ISOTOPES | Petnet Solutions, Inc. | 2026-10-31 | $1.09M |
| 36C26226F0051 PIFLUFOLASTAT F 18 - PYLARIFY | Progenics Pharmaceuticals Inc | 2026-10-31 | $1.08M |
| 36C26226F0031 DELIVERY ORDER FOR PYLARIFY | Progenics Pharmaceuticals Inc | 2026-11-03 | $5.02M |
Open notices
- 6505--Glipizide Tablets · Presolicitation · due 2026-10-08
- 6505--Prednisolone 1% Ophthalmic Solution · Solicitation · due 2026-10-14
- 6505--Notice of Intent to Sole-Source for Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) and Lutathera (Lutetium Lu 177 Dotatate) for Buffalo VA Medical Center · Special Notice · due 2026-10-15
- 6505--Prednisolone 1% Ophthalmic Solution · Presolicitation · due 2026-10-15
- Febuxostat Tablets · Solicitation · due 2026-10-15
- 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) · Presolicitation · due 2026-10-16
- Methylphenidate ER · Presolicitation · due 2026-10-23
- Methylphenidate ER · Solicitation · due 2026-10-23
From USAspending.gov prime awards and SAM.gov notices. Sources and limits